WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 16, 2005, 25(46):10689-10699; doi:10.1523/JNEUROSCI.3527-05.2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shults, C. W.
Right arrow Articles by Masliah, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shults, C. W.
Right arrow Articles by Masliah, E.

 Previous Article  |  Next Article 

Neurobiology of Disease
Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human {alpha}-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy

Clifford W. Shults,1,2 Edward Rockenstein,1 Leslie Crews,1 Anthony Adame,1 Michael Mante,1 Gabriel Larrea,1 Makoto Hashimoto,1 David Song,1,2 Takeshi Iwatsubo,3 Kyoko Tsuboi,1,2 and Eliezer Masliah1,4

1Department of Neurosciences, University of California, San Diego, La Jolla, California 92093-0624, 2Veterans Affairs San Diego Healthcare System, San Diego, California 92161, 3Department of Neuropathology and Neuroscience, University of Tokyo, Tokyo 113-0033, Japan, and 4Department of Pathology, University of California, San Diego, La Jolla, California 92093-0820

Multiple system atrophy (MSA) is a progressive, neurodegenerative disease characterized by parkinsonism, ataxia, autonomic dysfunction, and accumulation of {alpha}-synuclein ({alpha}-syn) in oligodendrocytes. To better understand the mechanisms of neurodegeneration and the role of {alpha}-syn accumulation in oligodendrocytes in the pathogenesis of MSA, we generated transgenic mouse lines expressing human (h) {alpha}-syn under the control of the murine myelin basic protein promoter. Transgenic mice expressing high levels of h{alpha}-syn displayed severe neurological alterations and died prematurely at 6 months of age. Furthermore, mice developed progressive accumulation of h{alpha}-syn-immunoreactive inclusions in oligodendrocytes along the axonal tracts in the brainstem, basal ganglia, cerebellum, corpus callosum, and neocortex. The inclusions also reacted with antibodies against phospho-serine (129) h{alpha}-syn and ubiquitin, and h{alpha}-syn was found in the detergent-insoluble fraction. In high-expresser lines, the white matter tracts displayed intense astrogliosis, myelin pallor, and decreased neurofilament immunostaining. Accumulation of h{alpha}-syn in oligodendrocytes also leads to prominent neurodegenerative changes in the neocortex with decreased dendritic density and to loss of dopaminergic fibers in the basal ganglia. The oligodendrocytic inclusions were composed of fibrils and accompanied by mitochondrial alterations and disruption of the myelin lamina in the axons. Together, these studies support the contention that accumulation of {alpha}-syn in oligodendrocytes promotes neurodegeneration and recapitulates several of the key functional and neuropathological features of MSA.

Key words: {alpha}-synuclein; Lewy body disease; multiple system atrophy (MSA); transgenic; myelin basic protein (MBP) promoter; oxidative stress


Received Oct 29, 2004; revised October 5, 2005; accepted October 5, 2005.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
J. Boy, T. Schmidt, H. Wolburg, A. Mack, S. Nuber, M. Bottcher, I. Schmitt, C. Holzmann, F. Zimmermann, A. Servadio, et al.
Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3
Hum. Mol. Genet., November 15, 2009; 18(22): 4282 - 4295.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. E. Benarroch
Oligodendrocytes: Susceptibility to injury and involvement in neurologic disease
Neurology, May 19, 2009; 72(20): 1779 - 1785.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. L. Kragh, L. B. Lund, F. Febbraro, H. D. Hansen, W.-P. Gai, O. El-Agnaf, C. Richter-Landsberg, and P. H. Jensen
{alpha}-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells
J. Biol. Chem., April 10, 2009; 284(15): 10211 - 10222.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Nakayama, Y. Suzuki, and I. Yazawa
Microtubule Depolymerization Suppresses {alpha}-Synuclein Accumulation in a Mouse Model of Multiple System Atrophy
Am. J. Pathol., April 1, 2009; 174(4): 1471 - 1480.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. J. C. Song, D. M.S. Lundvig, Y. Huang, W. P. Gai, P. C. Blumbergs, P. Hojrup, D. Otzen, G. M. Halliday, and P. H. Jensen
p25{alpha} Relocalizes in Oligodendroglia from Myelin to Cytoplasmic Inclusions in Multiple System Atrophy
Am. J. Pathol., October 1, 2007; 171(4): 1291 - 1303.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-